Pegasus Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-7,235
| Closed | -$203K | – | 77 |
|
|
2026
Q1 | $203K | Buy |
+7,235
| New | +$193K | 0.07% | 67 |
|
|
2025
Q2 | – | Sell |
-9,112
| Closed | -$231K | – | 74 |
|
|
2025
Q1 | $231K | Sell |
9,112
-1,732
| -16% | -$45.3K | 0.09% | 61 |
|
|
2024
Q4 | $288K | Sell |
10,844
-2,768
| -20% | -$75.1K | 0.11% | 57 |
|
|
2024
Q3 | $394K | Hold |
13,612
| – | – | 0.15% | 55 |
|
|
2024
Q2 | $381K | Hold |
13,612
| – | – | 0.15% | 59 |
|
|
2024
Q1 | $378K | Sell |
13,612
-235
| -2% | -$6.52K | 0.15% | 60 |
|
|
2023
Q4 | $399K | Sell |
13,847
-348
| -2% | -$10.5K | 0.17% | 60 |
|
|
2023
Q3 | $471K | Sell |
14,195
-1,313
| -8% | -$46.4K | 0.22% | 58 |
|
|
2023
Q2 | $569K | Sell |
15,508
-75
| -0.5% | -$2.92K | 0.25% | 57 |
|
|
2023
Q1 | $636K | Sell |
15,583
-20
| -0.1% | -$864 | 0.32% | 51 |
|
|
2022
Q4 | $799K | Sell |
15,603
-340
| -2% | -$16.3K | 0.43% | 48 |
|
|
2022
Q3 | $698K | Hold |
15,943
| – | – | 0.39% | 53 |
|
|
2022
Q2 | $836K | Hold |
15,943
| – | – | 0.45% | 49 |
|
|
2022
Q1 | $825K | Sell |
15,943
-12
| -0.1% | -$623 | 0.36% | 57 |
|
|
2021
Q4 | $942K | Buy |
15,955
+12
| +0.1% | +$595 | 0.39% | 55 |
|
|
2021
Q3 | $686K | Hold |
15,943
| – | – | 0.31% | 62 |
|
|
2021
Q2 | $624K | Hold |
15,943
| – | – | 0.29% | 62 |
|
|
2021
Q1 | $578K | Buy |
15,943
+1,190
| +8% | +$42.3K | 0.29% | 62 |
|
|
2020
Q4 | $543K | Sell |
14,753
-711
| -5% | -$26.1K | 0.3% | 60 |
|
|
2020
Q3 | $538K | Hold |
15,464
| – | – | 0.34% | 59 |
|
|
2020
Q2 | $480K | Sell |
15,464
-422
| -3% | -$14.3K | 0.33% | 57 |
|
|
2020
Q1 | $491K | Sell |
15,886
-831
| -5% | -$28.3K | 0.41% | 52 |
|
|
2019
Q4 | $621K | Buy |
16,717
+199
| +1% | +$7.09K | 0.41% | 54 |
|
|
2019
Q3 | $563K | Sell |
16,518
-3,057
| -16% | -$111K | 0.41% | 55 |
|
|
2019
Q2 | $805K | Sell |
19,575
-1,452
| -7% | -$57.7K | 0.62% | 49 |
|
|
2019
Q1 | $847K | Sell |
21,027
-527
| -2% | -$21.1K | 0.7% | 46 |
|
|
2018
Q4 | $893K | Hold |
21,554
| – | – | 0.84% | 42 |
|
|
2018
Q3 | $901K | Sell |
21,554
-896
| -4% | -$34.5K | 0.75% | 45 |
|
|
2018
Q2 | $773K | Sell |
22,450
-1,054
| -4% | -$36K | 0.72% | 48 |
|
|
2018
Q1 | $791K | Sell |
23,504
-766
| -3% | -$26.3K | 0.75% | 49 |
|
|
2017
Q4 | $834K | Buy |
+24,270
| New | +$828K | 0.83% | 47 |
|
Other funds holding PFE
Pegasus Asset Management's PFE Position: Q2 2026 in Review
Pegasus Asset Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,235 shares — an estimated $203K sold.
Pegasus Asset Management first reported a position in PFE in Q4 2017 and held it in 31 quarters. The position peaked at $942K in Q4 2021. 2,832 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Pegasus Asset Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Pegasus Asset Management sold 7,235 Pfizer shares in Q2 2026, an estimated $203K.
- Pegasus Asset Management first reported a position in Pfizer in Q4 2017 and held it in 31 quarters.
- Pegasus Asset Management's Pfizer position peaked at $942K in Q4 2021.
- 2,832 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Pegasus Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.